CAR T-Cell Therapy

CAR T-Cell Therapy

Project: Understanding CAR T-Cell Therapy: A Breakthrough in Cancer Treatment This animation provides a straightforward yet comprehensive explanation of how CAR T-cell therapy represents a powerful new tool in the fight against cancer. Our key task was to visualize a basic understanding of the immune system’s natural processes with these incredible scientific advancements that have…

Monoclonal antibodies

Monoclonal antibodies

Project: Targeting multiple myeloma with monoclonal antibodies The monoclonal antibody has become instrumental for the treatment of multiple myeloma. In this sequence, monoclonal antibodies have targeted CD38, a protein commonly expressed on the surface of cancerous plasma cells. Above: Monoclonal antibodies target CD38, a protein commonly expressed on the surface of cancerous plasma cells A…

Carcinoid Syndrome

Carcinoid Syndrome

Project: Sandostatin® LAR Depot MOA This sequence is an excerpt from a 5-minute MOA animation that examines the hypersecretion of hormones in carcinoid syndrome and an advanced biodegradable drug delivery system using polymer microsphere technology and slow release of octreotide. Above: assembly of a biodegradable glucose polymer microsphere Our client gave us a few unique challenges: depict…

Multiple Myeloma

Multiple Myeloma

Project: mAb targeting multiple myeloma MOASequence from 5-minute MOA that provides insight and details for a monoclonal antibody (mAb) designed to induce programmed tumor cell death (apoptosis) and immunomodulatory activity.  Above: Monoclonal antibodies designed to induce programmed tumor cell death (apoptosis) and immunomodulatory activity. For this mechanism of action video, our task was to create…

RNAi Therapy

RNAi Therapy

Project: RNAi Therapeutics: The Incredible Potential of siRNAs This mechanism-of-action animation highlights the therapeutic potential of small interfering RNAs (siRNAs), a powerful approach within RNA interference (RNAi), including an innovative siRNA delivery platform known as Targeted RNAi Molecules. Above: A view of siRNAs Many diseases stem from the overproduction of specific proteins or the presence…